{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:07:27Z","timestamp":1780304847973,"version":"3.54.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004091","name":"Kumamoto University","doi-asserted-by":"publisher","award":["CT27"],"award-info":[{"award-number":["CT27"]}],"id":[{"id":"10.13039\/501100004091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006004","name":"Tohoku University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006004","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K09675"],"award-info":[{"award-number":["JP20K09675"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K08896"],"award-info":[{"award-number":["JP23K08896"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.yexcr.2025.114773","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T07:00:25Z","timestamp":1758783625000},"page":"114773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Human trophoblast stem cell-differentiated syncytiotrophoblasts as a model for hypoxia-enhanced secretion of the anti-angiogenic factor sFLT1"],"prefix":"10.1016","volume":"452","author":[{"given":"Tadashi","family":"Sasagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masabumi","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2025.114773_bib1","first-page":"467","article-title":"Pre-eclampsia: pathophysiology, diagnosis, and management, Vasc","volume":"7","author":"Uzan","year":"2011","journal-title":"Health Risk Manag"},{"key":"10.1016\/j.yexcr.2025.114773_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.yexcr.2025.114773_bib3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.yexcr.2025.114773_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2025.114773_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00152-6","article-title":"A simple detection method for the serum sFLT1 protein in preeclampsia","volume":"11","author":"Shibuya","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2025.114773_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2183\/pjab.87.167","article-title":"Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia","volume":"87","author":"Shibuya","year":"2011","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.yexcr.2025.114773_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/HYPERTENSIONAHA.110.164079","article-title":"Expression of placental FLT1 transcript variants relates to both gestational hypertensive disease and fetal growth","volume":"58","author":"Jebbink","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.yexcr.2025.114773_bib8","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1095\/biolreprod59.6.1540","article-title":"A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation","volume":"59","author":"Clark","year":"1998","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.yexcr.2025.114773_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.placenta.2008.10.006","article-title":"Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women","volume":"30","author":"Rajakumar","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.yexcr.2025.114773_bib10","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1471-0528.2011.02962.x","article-title":"Placental expression of a novel primate-specific splice variant of sFlt-1 is upregulated in pregnancies complicated by severe early onset pre-eclampsia","volume":"118","author":"Whitehead","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.yexcr.2025.114773_bib11","doi-asserted-by":"crossref","first-page":"12436","DOI":"10.3390\/ijms160612436","article-title":"Circulating levels of sFlt1 splice variants as predictive markers for the development of preeclampsia","volume":"16","author":"Souders","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2025.114773_bib12","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1530\/JOE-17-0402","article-title":"Trophoblast lineage specification, differentiation and their regulation by oxygen tension","volume":"236","author":"Chang","year":"2018","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.yexcr.2025.114773_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/molehr\/7.2.205","article-title":"Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies","volume":"7","author":"Helske","year":"2001","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.yexcr.2025.114773_bib14","doi-asserted-by":"crossref","first-page":"R1085","DOI":"10.1152\/ajpregu.00794.2005","article-title":"Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1","volume":"291","author":"Nevo","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.yexcr.2025.114773_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/HYPERTENSIONAHA.111.182170","article-title":"Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"59","author":"Rajakumar","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.yexcr.2025.114773_bib16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.115.05883","article-title":"Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity","volume":"66","author":"Palmer","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.yexcr.2025.114773_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/HYPERTENSIONAHA.116.08408","article-title":"Proton pump inhibitors decrease soluble fms-like tyrosine kinase-1 and soluble endoglin secretion, decrease hypertension, and rescue endothelial dysfunction","volume":"69","author":"Onda","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.yexcr.2025.114773_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12884-016-0902-3","article-title":"Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta","volume":"16","author":"Brownfoot","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.yexcr.2025.114773_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512100","article-title":"New ideas for the prevention and treatment of preeclampsia and their molecular inspirations","volume":"24","author":"Sakowicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2025.114773_bib20","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.3390\/jcm12186020","article-title":"Recent advances in the prevention and screening of preeclampsia","volume":"12","author":"M\u00e9sz\u00e1ros","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.yexcr.2025.114773_bib21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/humupd\/dmaa017","article-title":"Investigation of human trophoblast invasion in vitro","volume":"26","author":"Abbas","year":"2020","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.yexcr.2025.114773_bib22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/biomedicines10040904","article-title":"In vitro model of human trophoblast in early placentation","volume":"10","author":"Ba\u010denkov\u00e1","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.yexcr.2025.114773_bib23","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41420-023-01670-0","article-title":"A comprehensive review of human trophoblast fusion models: recent developments and challenges","volume":"9","author":"Li","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.yexcr.2025.114773_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35745-1","article-title":"HIF-2\u03b1, but not HIF-1\u03b1, mediates hypoxia-induced up-regulation of Flt-1 gene expression in placental trophoblasts","volume":"8","author":"Sasagawa","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2025.114773_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12885-020-6598-9","article-title":"Production of an anti-angiogenic factor sFLT1 is suppressed via promoter hypermethylation of FLT1 gene in choriocarcinoma cells","volume":"20","author":"Sasagawa","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2025.114773_bib26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.stem.2017.11.004","article-title":"Derivation of human trophoblast stem cells","volume":"22","author":"Okae","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yexcr.2025.114773_bib27","doi-asserted-by":"crossref","first-page":"26606","DOI":"10.1073\/pnas.1916019116","article-title":"Loss of p57KIP2 expression confers resistance to contact inhibition in human androgenetic trophoblast stem cells","volume":"116","author":"Takahashi","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2025.114773_bib28","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2311372120","article-title":"CRISPR screening in human trophoblast stem cells reveals both shared and distinct aspects of human and mouse placental development","volume":"120","author":"Shimizu","year":"2023","journal-title":"Proc. Natl .Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2025.114773_bib29","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1371\/journal.pbio.0000083","article-title":"Inhibition of HIF2\u03b1 is sufficient to suppress pVHL-defective tumor growth","volume":"1","author":"Kondo","year":"2003","journal-title":"PLoS Biol."},{"key":"10.1016\/j.yexcr.2025.114773_bib30","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/sj.onc.1204228","article-title":"A variant of nuclear localization signal of bipartite-type is required for the nuclear translocation of hypoxia inducible factors (1alpha, 2alpha and 3alpha)","volume":"20","author":"Luo","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2025.114773_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113500","article-title":"CRISPR\/Cas9-mediated mutations in both a cAMP response element and an ETS-binding site suppress FLT1 gene expression","volume":"424","author":"Sasagawa","year":"2023","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2025.114773_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/molehr\/gaab065","article-title":"Hypoxia-inducible factor-1\u03b2 is essential for upregulation of the hypoxia-induced FLT1 gene in placental trophoblasts","volume":"27","author":"Sasagawa","year":"2021","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.yexcr.2025.114773_bib33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1349-7006.1997.tb00463.x","article-title":"Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase)","volume":"88","author":"Tanaka","year":"1997","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114773_bib34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood.V97.3.785","article-title":"Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans","volume":"97","author":"Sawano","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2025.114773_bib35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52504","article-title":"Derivation of trophoblast stem cells from na\u00efve human pluripotent stem cells","volume":"9","author":"Dong","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.yexcr.2025.114773_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2105130118","article-title":"MSX2 safeguards syncytiotrophoblast fate of human trophoblast stem cells","volume":"118","author":"Hornbachner","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2025.114773_bib37","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/jhh.2017.61","article-title":"Placental growth factor and pre-eclampsia","volume":"31","author":"Chau","year":"2017","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.yexcr.2025.114773_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12685-w","article-title":"Enhanced HIF2\u03b1 expression during human trophoblast differentiation into syncytiotrophoblast suppresses transcription of placental growth factor","volume":"7","author":"Fujii","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2025.114773_bib39","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3390\/biomedicines9050468","article-title":"HIF-\u03b1 prolyl hydroxylase inhibitors and their implications for biomedicine: a comprehensive review","volume":"9","author":"Hirota","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.yexcr.2025.114773_bib40","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tibs.2012.06.004","article-title":"Passing the baton: the HIF switch","volume":"37","author":"Koh","year":"2012","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.yexcr.2025.114773_bib41","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/HYPERTENSIONAHA.122.20739","article-title":"Specific HIF-2alpha (hypoxia-inducible factor-2) inhibitor PT2385 mitigates placental dysfunction in vitro and in a rat model of preeclampsia (RUPP)","volume":"80","author":"Colson","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.yexcr.2025.114773_bib42","first-page":"46","article-title":"Selective HIF2A inhibitors in the management of clear cell renal cancer and von hippel-lindau-disease associated tumors","volume":"11","author":"Su\u00e1rez","year":"2023","journal-title":"Med. Sci."},{"key":"10.1016\/j.yexcr.2025.114773_bib43","doi-asserted-by":"crossref","first-page":"23659","DOI":"10.1074\/jbc.272.38.23659","article-title":"Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1\/KDR, is up-regulated by hypoxia","volume":"272","author":"Gerber","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2025.114773_bib44","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1038\/s41598-018-21524-5","article-title":"Consequences of VHL loss on global DNA methylome","volume":"8","author":"Robinson","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2025.114773_bib45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/08977199609003217","article-title":"Characterization of the promoter region for flt-1 tyrosine kinase gene, a receptor for vascular endothelial growth factor","volume":"13","author":"Ikeda","year":"1996","journal-title":"Growth Factors"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725003738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725003738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:34:35Z","timestamp":1780302875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482725003738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0014482725003738"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114773","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human trophoblast stem cell-differentiated syncytiotrophoblasts as a model for hypoxia-enhanced secretion of the anti-angiogenic factor sFLT1","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114773"}}